Physician profile
Troy E Callahan
NPI 1962444976
$6,401.57
in general payments reported to CMS, 2019-2025
9 companies · $299 in 2025
The $299 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,932 · 2021: $47.76 · 2022: $199 · 2023: $323 · 2024: $3,600 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $3,600 · Food and Beverage: $623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $3,600.00 |
| Food and Beverage | $622.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $3,600.00 | 2024 | |
| Allergan, INC. | $1,939.05 | 2019-2022 | |
| Tela Bio, INC. | $250.00 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $181.50 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Boston Scientific Corporation | $164.67 | 2023 | |
| Medtronic, INC. | $138.26 | 2023 | Intellis Adaptivestim |
| Sientra, INC. | $64.80 | 2021-2022 | |
| Davol INC. | $47.89 | 2025 | Channel Drain |
| Axogen | $15.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Callahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.